Alzheimer's disease, cerebral blood flow, and nitric oxide.
Toda
Noboru
N
ntoda.toyama-bldg@orion.ocn.ne.jp
Ayajiki
Kazuhide
K
D000109:Acetylcholine / Q000502:physiology; D000544:Alzheimer Disease / Q000209:etiology / Q000503:physiopathology / Q000517:prevention & control / Q000628:therapy; D016229:Amyloid beta-Peptides / Q000378:metabolism / Q000502:physiology; D000818:Animals; D001921:Brain / Q000378:metabolism; D002560:Cerebrovascular Circulation; D002800:Cholinesterase Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D009569:Nitric Oxide / Q000378:metabolism / Q000502:physiology; D052247:Nitric Oxide Synthase Type II / Q000037:antagonists & inhibitors
D016229:Amyloid beta-Peptides; D002800:Cholinesterase Inhibitors; D009569:Nitric Oxide; D052247:Nitric Oxide Synthase Type II; D000109:Acetylcholine